nVerses Capital’s Pulmonx LUNG Stock Holding History

nVerses Capital’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,100	Closed	-$25.7K	–	493
2024 Q3	$25.7K	Buy	+3,100	New	+$22.4K	0.01%	764

Other funds holding LUNG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

nVerses Capital's LUNG Position: Q4 2024 in Review

nVerses Capital sold out of Pulmonx (LUNG) in Q4 2024, closing a stake of 3,100 shares — an estimated $25.7K sold.

nVerses Capital first reported a position in LUNG in Q3 2024 and held it in 1 quarter. The position peaked at $25.7K in Q3 2024. 118 funds tracked by Wall St. Rank hold LUNG as of Q4 2024.

nVerses Capital reported no remaining Pulmonx position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 3,100 Pulmonx shares in Q4 2024, an estimated $25.7K.
nVerses Capital first reported a position in Pulmonx in Q3 2024 and held it in 1 quarter.
nVerses Capital's Pulmonx position peaked at $25.7K in Q3 2024.
118 funds tracked by Wall St. Rank held Pulmonx as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.